BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11291047)

  • 1. Deletion mapping of chromosome segment 11q24-q25, exhibiting extensive allelic loss in early onset breast cancer.
    Gentile M; Wiman A; Thorstenson S; Loman N; Borg A; Wingren S
    Int J Cancer; 2001 Apr; 92(2):208-13. PubMed ID: 11291047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent allelic losses at 11q24.1-q25 in young women with breast cancer: association with poor survival.
    Gentile M; Olsen K; Dufmats M; Wingren S
    Br J Cancer; 1999 May; 80(5-6):843-9. PubMed ID: 10360664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of different deleted regions in chromosome 11 and their interrelations in early- and late-onset breast tumors: association with cyclin D1 amplification and survival.
    Chunder N; Mandal S; Roy A; Roychoudhury S; Panda CK
    Diagn Mol Pathol; 2004 Sep; 13(3):172-82. PubMed ID: 15322430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations.
    Gudmundsson J; Barkardottir RB; Eiriksdottir G; Baldursson T; Arason A; Egilsson V; Ingvarsson S
    Br J Cancer; 1995 Sep; 72(3):696-701. PubMed ID: 7669583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 11q22.3-q25 LOH in ovarian cancer: association with a more aggressive disease course and involved subregions.
    Launonen V; Stenbäck F; Puistola U; Bloigu R; Huusko P; Kytölä S; Kauppila A; Winqvist R
    Gynecol Oncol; 1998 Nov; 71(2):299-304. PubMed ID: 9826475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion.
    Noviello C; Courjal F; Theillet C
    Clin Cancer Res; 1996 Sep; 2(9):1601-6. PubMed ID: 9816339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
    Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
    Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset).
    Lo YL; Yu JC; Huang CS; Tseng SL; Chang TM; Chang KJ; Wu CW; Shen CY
    Int J Cancer; 1998 Dec; 79(6):580-7. PubMed ID: 9842965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two distinct tumor suppressor loci within chromosome 11p15 implicated in breast cancer progression and metastasis.
    Karnik P; Paris M; Williams BR; Casey G; Crowe J; Chen P
    Hum Mol Genet; 1998 May; 7(5):895-903. PubMed ID: 9536095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic deletions at chromosome 11q22-q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers.
    Koreth J; Bakkenist CJ; McGee JO
    Oncogene; 1997 Jan; 14(4):431-7. PubMed ID: 9053840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic loss of chromosomal arm 8p in breast cancer progression.
    Anbazhagan R; Fujii H; Gabrielson E
    Am J Pathol; 1998 Mar; 152(3):815-9. PubMed ID: 9502423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors.
    Johannsdottir HK; Jonsson G; Johannesdottir G; Agnarsson BA; Eerola H; Arason A; Heikkila P; Egilsson V; Olsson H; Johannsson OT; Nevanlinna H; Borg A; Barkardottir RB
    Int J Cancer; 2006 Sep; 119(5):1052-60. PubMed ID: 16570289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion mapping of chromosome 1 in early onset and late onset breast tumors--a comparative study in eastern India.
    Chunder N; Mandal S; Basu D; Roy A; Roychoudhury S; Panda CK
    Pathol Res Pract; 2003; 199(5):313-21. PubMed ID: 12908521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletions on chromosome 4 in sporadic and BRCA mutated tumors and association with pathological variables.
    Johannsdottir HK; Johannesdottir G; Agnarsson BA; Eerola H; Arason A; Johannsson OT; Heikkilä P; Egilsson V; Olsson H; Borg A; Nevanlinna H; Barkardottir RB
    Anticancer Res; 2004; 24(5A):2681-7. PubMed ID: 15521105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A region close to Tp53 shows LOH in familial breast cancer.
    Luo L; Chen J; Du Q; Dumanski J; Blennow E; Kockum I; Luthman H; Lindblom A
    Int J Mol Med; 2002 Apr; 9(4):405-9. PubMed ID: 11891537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
    Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS
    Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent loss of the BLID gene in early-onset breast cancer.
    Cavalli LR; Noone AM; Makambi KH; Rone JD; Kasid UN; Haddad BR
    Cytogenet Genome Res; 2011; 135(1):19-24. PubMed ID: 21846966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium.
    Laake K; Launonen V; Niederacher D; Gudlaugsdottir S; Seitz S; Rio P; Champème MH; Bièche I; Birnbaum D; White G; Sztan M; Sever N; Plummer S; Osorio A; Broeks A; Huusko P; Spurr N; Borg A; Cleton-Jansen AM; van't Veer L; Benitez J; Casey G; Peterlin B; Olah E; Børresen-Dale AL
    Genes Chromosomes Cancer; 1999 Jul; 25(3):212-21. PubMed ID: 10379867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis.
    Winqvist R; Hampton GM; Mannermaa A; Blanco G; Alavaikko M; Kiviniemi H; Taskinen PJ; Evans GA; Wright FA; Newsham I
    Cancer Res; 1995 Jun; 55(12):2660-4. PubMed ID: 7780982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.